Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--
Combination chemotherapy for small cell carcinoma of the lung
โ Scribed by E. D. Gilby; Professor P. K. Bondy; R. L. Morgan; T. J. McElwain
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 575 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The development of drug resistance limits the survival or patients with small cell anaplastic carcinoma of the lung (SCLC). The present study was undertaken to overcome this problem by administering two alternating noncross resistant combination chemotherapy regimens. One-hundred-one patients were e
Twenty-eight patients with small cell carcinoma of the lung were studied for their response to combination chemotherapy and radiation therapy, frequency of bone marrow metastases, and clinically evident hormonal syndromes. Seventeen of 19 evaluable patients who received cyclic monthly courses of hig